This webinar will address the most important steps in a roadmap to bring biosimilar, generic, and complex generic drugs through U.S. FDA filings and into the U.S. market.
Subject area:
cGMP
Objectives (If applicable):
N/A
Target Audience (If applicable):
Drug developers, drug manufacturing, pharmaceutical manufacturing, QA/QC professionals, portfolio managers, RA/ Regulatory operations, Quality managers, scientists, engineers, CDMOs / CROs, CMO/CTO/CEO